Cite
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
MLA
Ashwin Govindan, et al. “Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide.” Case Reports in Oncology, vol. 13, no. 3, Oct. 2020, pp. 1244–51. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2079d5426aaf2fd958b9b09bd2cc9ccf&authtype=sso&custid=ns315887.
APA
Ashwin Govindan, Nigel C. Harrison, Karam Khaddour, & Jian Campian. (2020). Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide. Case Reports in Oncology, 13(3), 1244–1251.
Chicago
Ashwin Govindan, Nigel C. Harrison, Karam Khaddour, and Jian Campian. 2020. “Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide.” Case Reports in Oncology 13 (3): 1244–51. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2079d5426aaf2fd958b9b09bd2cc9ccf&authtype=sso&custid=ns315887.